FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025784647> ?p ?o ?g. }

• W2025784647 endingPage "1997" @default.
• W2025784647 startingPage "1988" @default.
• W2025784647 abstract "Dysferlinopathies are a heterogenous group of autosomal recessive inherited muscular dystrophies caused by mutations in DYSF gene. Dysferlin is expressed mainly in skeletal muscle and in monocytes and patients display a severe reduction or absence of protein in both tissues. Vitamin D3 promotes differentiation of the promyelocytic leukemia HL60 cells. We analyzed the effect of vitamin D3 on dysferlin expression in vitro using HL60 cells, monocytes and myotubes from controls and carriers of a single mutation in DYSF. We also performed an observational study with oral vitamin D3 in a cohort of 21 carriers. Fifteen subjects were treated for 1 year and dysferlin expression in monocytes was analysed before and after treatment. Treatment with vitamin D3 increased expression of dysferlin in vitro. The effect of vitamin D3 was mediated by both a nongenomic pathway through MEK/ERK and a genomic pathway involving binding of vitamin D3 receptor to the dysferlin promoter. Carriers treated with vitamin D3 had significantly increased expression of dysferlin in monocytes compared with nontreated carriers (P < 0.05). These findings will have important therapeutic implications since a combination of different molecular strategies together with vitamin D3 uptake could increase dysferlin expression to nonpathological protein levels. Dysferlinopathies are a heterogenous group of autosomal recessive inherited muscular dystrophies caused by mutations in DYSF gene. Dysferlin is expressed mainly in skeletal muscle and in monocytes and patients display a severe reduction or absence of protein in both tissues. Vitamin D3 promotes differentiation of the promyelocytic leukemia HL60 cells. We analyzed the effect of vitamin D3 on dysferlin expression in vitro using HL60 cells, monocytes and myotubes from controls and carriers of a single mutation in DYSF. We also performed an observational study with oral vitamin D3 in a cohort of 21 carriers. Fifteen subjects were treated for 1 year and dysferlin expression in monocytes was analysed before and after treatment. Treatment with vitamin D3 increased expression of dysferlin in vitro. The effect of vitamin D3 was mediated by both a nongenomic pathway through MEK/ERK and a genomic pathway involving binding of vitamin D3 receptor to the dysferlin promoter. Carriers treated with vitamin D3 had significantly increased expression of dysferlin in monocytes compared with nontreated carriers (P < 0.05). These findings will have important therapeutic implications since a combination of different molecular strategies together with vitamin D3 uptake could increase dysferlin expression to nonpathological protein levels." @default.
• W2025784647 created "2016-06-24" @default.
• W2025784647 creator A5003199280 @default.
• W2025784647 creator A5014239140 @default.
• W2025784647 creator A5020911584 @default.
• W2025784647 creator A5036594097 @default.
• W2025784647 creator A5041593057 @default.
• W2025784647 creator A5046918434 @default.
• W2025784647 creator A5048129993 @default.
• W2025784647 creator A5056359893 @default.
• W2025784647 creator A5071887992 @default.
• W2025784647 creator A5074226481 @default.
• W2025784647 date "2012-10-01" @default.
• W2025784647 modified "2023-10-06" @default.
• W2025784647 title "1α,25(OH)2-Vitamin D3 Increases Dysferlin Expression in vitro and in a Human Clinical Trial" @default.
• W2025784647 cites W1551910894 @default.
• W2025784647 cites W1563834930 @default.
• W2025784647 cites W1592698849 @default.
• W2025784647 cites W1911104948 @default.
• W2025784647 cites W1967770170 @default.
• W2025784647 cites W1972231896 @default.
• W2025784647 cites W1982268478 @default.
• W2025784647 cites W1987040411 @default.
• W2025784647 cites W1990919095 @default.
• W2025784647 cites W1991817429 @default.
• W2025784647 cites W1994513923 @default.
• W2025784647 cites W1998139299 @default.
• W2025784647 cites W1999379258 @default.
• W2025784647 cites W1999477428 @default.
• W2025784647 cites W2001819224 @default.
• W2025784647 cites W2003054277 @default.
• W2025784647 cites W2005675731 @default.
• W2025784647 cites W2013655209 @default.
• W2025784647 cites W2016438201 @default.
• W2025784647 cites W2016692832 @default.
• W2025784647 cites W2016759486 @default.
• W2025784647 cites W2023788128 @default.
• W2025784647 cites W2031507542 @default.
• W2025784647 cites W2039847498 @default.
• W2025784647 cites W2045584862 @default.
• W2025784647 cites W2052561467 @default.
• W2025784647 cites W2066799043 @default.
• W2025784647 cites W2067458775 @default.
• W2025784647 cites W2076939004 @default.
• W2025784647 cites W2082198146 @default.
• W2025784647 cites W2086262311 @default.
• W2025784647 cites W2088843714 @default.
• W2025784647 cites W2095351093 @default.
• W2025784647 cites W2102958109 @default.
• W2025784647 cites W2104829608 @default.
• W2025784647 cites W2112697515 @default.
• W2025784647 cites W2112830920 @default.
• W2025784647 cites W2120117397 @default.
• W2025784647 cites W2128840922 @default.
• W2025784647 cites W2137461061 @default.
• W2025784647 cites W2146266794 @default.
• W2025784647 cites W2149644790 @default.
• W2025784647 cites W2154413314 @default.
• W2025784647 cites W2154756699 @default.
• W2025784647 cites W2318686843 @default.
• W2025784647 doi "https://doi.org/10.1038/mt.2012.156" @default.
• W2025784647 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3464637" @default.
• W2025784647 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22910291" @default.
• W2025784647 hasPublicationYear "2012" @default.
• W2025784647 type Work @default.
• W2025784647 sameAs 2025784647 @default.
• W2025784647 citedByCount "15" @default.
• W2025784647 countsByYear W20257846472013 @default.
• W2025784647 countsByYear W20257846472014 @default.
• W2025784647 countsByYear W20257846472016 @default.
• W2025784647 countsByYear W20257846472017 @default.
• W2025784647 countsByYear W20257846472018 @default.
• W2025784647 countsByYear W20257846472019 @default.
• W2025784647 countsByYear W20257846472020 @default.
• W2025784647 countsByYear W20257846472022 @default.
• W2025784647 crossrefType "journal-article" @default.
• W2025784647 hasAuthorship W2025784647A5003199280 @default.
• W2025784647 hasAuthorship W2025784647A5014239140 @default.
• W2025784647 hasAuthorship W2025784647A5020911584 @default.
• W2025784647 hasAuthorship W2025784647A5036594097 @default.
• W2025784647 hasAuthorship W2025784647A5041593057 @default.
• W2025784647 hasAuthorship W2025784647A5046918434 @default.
• W2025784647 hasAuthorship W2025784647A5048129993 @default.
• W2025784647 hasAuthorship W2025784647A5056359893 @default.
• W2025784647 hasAuthorship W2025784647A5071887992 @default.
• W2025784647 hasAuthorship W2025784647A5074226481 @default.
• W2025784647 hasBestOaLocation W20257846471 @default.
• W2025784647 hasConcept C104317684 @default.
• W2025784647 hasConcept C126322002 @default.
• W2025784647 hasConcept C134018914 @default.
• W2025784647 hasConcept C2776601000 @default.
• W2025784647 hasConcept C2776940978 @default.
• W2025784647 hasConcept C2779959927 @default.
• W2025784647 hasConcept C2781121885 @default.
• W2025784647 hasConcept C37113945 @default.
• W2025784647 hasConcept C3763915 @default.
• W2025784647 hasConcept C502942594 @default.
• W2025784647 hasConcept C55493867 @default.

• next